Correlation Between BRIM Biotechnology and GrandTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BRIM Biotechnology and GrandTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BRIM Biotechnology and GrandTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BRIM Biotechnology and GrandTech CG Systems, you can compare the effects of market volatilities on BRIM Biotechnology and GrandTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BRIM Biotechnology with a short position of GrandTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BRIM Biotechnology and GrandTech.

Diversification Opportunities for BRIM Biotechnology and GrandTech

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between BRIM and GrandTech is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding BRIM Biotechnology and GrandTech CG Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GrandTech CG Systems and BRIM Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BRIM Biotechnology are associated (or correlated) with GrandTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GrandTech CG Systems has no effect on the direction of BRIM Biotechnology i.e., BRIM Biotechnology and GrandTech go up and down completely randomly.

Pair Corralation between BRIM Biotechnology and GrandTech

Assuming the 90 days trading horizon BRIM Biotechnology is expected to generate 2.04 times more return on investment than GrandTech. However, BRIM Biotechnology is 2.04 times more volatile than GrandTech CG Systems. It trades about 0.23 of its potential returns per unit of risk. GrandTech CG Systems is currently generating about 0.3 per unit of risk. If you would invest  2,900  in BRIM Biotechnology on November 28, 2024 and sell it today you would earn a total of  115.00  from holding BRIM Biotechnology or generate 3.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy58.82%
ValuesDaily Returns

BRIM Biotechnology  vs.  GrandTech CG Systems

 Performance 
       Timeline  
BRIM Biotechnology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BRIM Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
GrandTech CG Systems 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in GrandTech CG Systems are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GrandTech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BRIM Biotechnology and GrandTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BRIM Biotechnology and GrandTech

The main advantage of trading using opposite BRIM Biotechnology and GrandTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BRIM Biotechnology position performs unexpectedly, GrandTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GrandTech will offset losses from the drop in GrandTech's long position.
The idea behind BRIM Biotechnology and GrandTech CG Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk